ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Investor Alert: Lawsuit Alleges Misleading Statements
An investor, who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by ACADIA Pharmaceuticals Inc. in connection with certain allegedly false and misleading statements made between February 26, 2015 and March 11, 2015.
View full press release